LabGenius
London
About LabGenius
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $73.1M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: labgeni.us
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Robotics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/labgenius-34333 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.